HMOX1 and central nervous system cancer: The data revealed that high SPP1/HMOX1 expression is positively related to patient age, IDH WT status, 1p/19q codeletion, and primary treatment outcome (Figure 3E,F), suggesting that SPP1 and HMOX1 play crucial roles in the progression of glioma (p < 0.001).